Gossamer Bio Newsroom

Gossamer Bio (GOSS) Gets a Buy From Oppenheimer

TipRanksNov 12 07:52 ET

HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target

BenzingaNov 11 10:11 ET

Gossamer Bio Analyst Ratings

BenzingaNov 11 10:10 ET

Promising Progress and Expansion Potential of Gossamer Bio's Seralutinib Drive Buy Rating

TipRanksNov 11 06:23 ET

Oppenheimer Maintains Gossamer Bio(GOSS.US) With Buy Rating, Raises Target Price to $9

Moomoo NewsSep 16 08:31 ET

Gossamer Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow JonesAug 30 05:52 ET

Goldman Sachs Maintains Gossamer Bio(GOSS.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsAug 14 07:31 ET

Buy Rating Affirmed for Gossamer Bio Amidst Financial Growth and Clinical Advancements

TipRanksAug 14 06:37 ET

Barclays Reaffirms Their Hold Rating on Gossamer Bio (GOSS)

TipRanksAug 14 03:53 ET

Gossamer Bio Analyst Ratings

BenzingaAug 13 08:31 ET

Piper Sandler Keeps Their Buy Rating on Gossamer Bio (GOSS)

TipRanksAug 13 06:53 ET

Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX), Spruce Biosciences (SPRB) and Gossamer Bio (GOSS)

TipRanksAug 13 06:53 ET

Gossamer Bio (GOSS) Receives a Buy From Piper Sandler

TipRanksJul 15 06:51 ET

Gossamer Bio Analyst Ratings

BenzingaJun 25 05:40 ET

Gossamer Bio Analyst Ratings

BenzingaJun 17 12:45 ET

Buy Rating Reaffirmed for Gossamer Bio on Seralutinib's Promising Clinical Data and Future Prospects

TipRanksMay 20 11:30 ET

Gossamer Bio Analyst Ratings

BenzingaMay 20 11:10 ET

HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target

BenzingaMay 20 11:10 ET

Buy Rating Affirmed for Gossamer Bio Amidst Strategic Collaboration and Market Opportunity Growth

TipRanksMay 9 12:50 ET

Gossamer Bio Analyst Ratings

BenzingaMay 8 10:21 ET